These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 22530790)
1. Emerging drugs for major depressive disorder: an update. Rizvi SJ; Kennedy SH Expert Opin Emerg Drugs; 2012 Sep; 17(3):285-94. PubMed ID: 22530790 [No Abstract] [Full Text] [Related]
2. New perspectives on glutamate receptor antagonists as antidepressants. Chung C Arch Pharm Res; 2012 Mar; 35(4):573-7. PubMed ID: 22553049 [TBL] [Abstract][Full Text] [Related]
3. Could the underestimation of bipolarity obstruct the search for novel antidepressant drugs? Fornaro M; Aguglia E; Dell'Osso L; Perugi G Expert Opin Pharmacother; 2011 Dec; 12(18):2817-31. PubMed ID: 22098226 [TBL] [Abstract][Full Text] [Related]
9. Desvenlafaxine in the treatment of major depressive disorder. Pae CU Expert Opin Pharmacother; 2011 Dec; 12(18):2923-8. PubMed ID: 22098230 [TBL] [Abstract][Full Text] [Related]
10. Antidepressant treatment practice in the face of STAR*D and STEP-BD. Cassidy F Bipolar Disord; 2008 Dec; 10(8):973-4. PubMed ID: 19594512 [No Abstract] [Full Text] [Related]
12. Effects of antidepressants in patients with irritable bowel syndrome and comorbid depression. Friedrich M; Grady SE; Wall GC Clin Ther; 2010 Jul; 32(7):1221-33. PubMed ID: 20678672 [TBL] [Abstract][Full Text] [Related]
13. Likelihood to be helped or harmed can assist in clinical decision-making. Citrome L J Clin Psychiatry; 2011 Feb; 72(2):261-2; author reply 262. PubMed ID: 21382311 [No Abstract] [Full Text] [Related]
14. Sponsorship, antidepressant dose, and outcome in major depressive disorder: meta-analysis of randomized controlled trials. Sinyor M; Schaffer A; Smart KA; Levitt AJ; Lanctôt KL; Grysman NH J Clin Psychiatry; 2012 Feb; 73(2):e277-87. PubMed ID: 22401489 [TBL] [Abstract][Full Text] [Related]
15. Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders. Montgomery SA Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S9-15; discussion S16-7. PubMed ID: 12685917 [TBL] [Abstract][Full Text] [Related]
16. Initial treatment approaches for patients with major depressive disorder. Papakostas GI J Clin Psychiatry; 2009 Jun; 70(6):e18. PubMed ID: 19573474 [TBL] [Abstract][Full Text] [Related]
17. Augmentation strategies in the treatment of major depressive disorder. Clinical considerations with atypical antipsychotic augmentation. Gitlin MJ CNS Spectr; 2007 Dec; 12(12 Suppl 22):13-5. PubMed ID: 18389929 [No Abstract] [Full Text] [Related]
18. Diabetes mellitus and major depressive disorder: an overview of prevalence, complications, and treatment. Carney C Depress Anxiety; 1998; 7(4):149-57. PubMed ID: 9706451 [No Abstract] [Full Text] [Related]
19. Treatment of psychotic depression in the elderly compared with nonpsychotic depression. Kok R; Heeren T; Nolen W J Clin Psychopharmacol; 2010 Aug; 30(4):465-7. PubMed ID: 20631567 [No Abstract] [Full Text] [Related]
20. Genetic studies of drug response and side effects in the STAR*D study, part 1. Garriock HA; Hamilton SP J Clin Psychiatry; 2009 Aug; 70(8):1186-7. PubMed ID: 19758527 [No Abstract] [Full Text] [Related] [Next] [New Search]